Trial · NCT01014767
Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
NCT01014767, Phase 3, Terminated, Tufts Medical Center; results first posted 2019-08-20
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors. Trials, record NCT01014767. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01014767
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors
- NCT number
- NCT01014767
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 27 participants, actual
- Lead sponsor
- Tufts Medical Center
- Conditions
- Brain Cancer, Choroid Plexus Tumors
- Interventions
- Carboplatin, Cisplatin, Cyclophosphamide, Dactinomycin, Doxorubicin, Etoposide, Irinotecan, Leucovorin, Methotrexate, Temozolomide, Vincristine
- First posted
- 2009-11-17
- Last updated
- 2019-08-20
- Results first posted
- 2019-08-20
- Limitations and caveats
- Data unavailable at sponsoring institution due to departure of PI. Data were stored and analyzed centrally at another site.
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to Disease Progression | Till disease progression or death (up to 6 cycles of 28-day treatment) | PI is no longer with the institution. All efforts have been exhausted to locate this data, but this data is no longer available |
| Primary | Toxicity During First 4 Months of Therapy | 4 Months | PI is no longer with the institution. All efforts have been exhausted to locate this data, but this data is no longer available |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Time to Disease Progression | Till disease progression or death (up to 6 cycles of 28-day treatment) | PI is no longer with the institution. All efforts have been exhausted to locate this data, but this data is no longer available | ||
| PRIMARY | Toxicity During First 4 Months of Therapy | 4 Months | PI is no longer with the institution. All efforts have been exhausted to locate this data, but this data is no longer available |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow12
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Standard Arm (1) | 12 | |
| Overall Study | STARTED | Doxorubicin/Cisplatin Arm (2) | 1 | |
| Overall Study | STARTED | Methotrexate Arm (3) | 4 | |
| Overall Study | STARTED | Temozolomide Irinotecan Arm (4) | 1 | |
| Overall Study | COMPLETED | Standard Arm (1) | 0 | |
| Overall Study | COMPLETED | Doxorubicin/Cisplatin Arm (2) | 0 | |
| Overall Study | COMPLETED | Methotrexate Arm (3) | 0 | |
| Overall Study | COMPLETED | Temozolomide Irinotecan Arm (4) | 0 | |
| Overall Study | NOT COMPLETED | Standard Arm (1) | 12 | |
| Overall Study | NOT COMPLETED | Doxorubicin/Cisplatin Arm (2) | 1 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals12
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Standard Arm (1) | 0 | 0 |
| Total, all-cause mortality | Doxorubicin/Cisplatin Arm (2) | 0 | 0 |
| Total, all-cause mortality | Methotrexate Arm (3) | 0 | 0 |
| Total, all-cause mortality | Temozolomide Irinotecan Arm (4) | 0 | 0 |
| Total, other adverse events | Standard Arm (1) | 0 | 0 |
| Total, other adverse events | Doxorubicin/Cisplatin Arm (2) | 0 | 0 |
| Total, other adverse events | Methotrexate Arm (3) | 0 | 0 |
| Total, other adverse events | Temozolomide Irinotecan Arm (4) | 0 | 0 |
| Total, serious adverse events | Standard Arm (1) | 0 | 0 |
| Total, serious adverse events | Doxorubicin/Cisplatin Arm (2) | 0 | 0 |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 adverse event totalsPapers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01014767
GET https://conductscience.org/api/trials/v1/NCT01014767/registered